KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Other financing activities (2016 - 2025)

National Health Investors (NHI) has disclosed Other financing activities for 15 consecutive years, with $3.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other financing activities rose 333.49% year-over-year to $3.7 million, compared with a TTM value of $3.9 million through Dec 2025, up 317.31%, and an annual FY2025 reading of $3.9 million, up 317.31% over the prior year.
  • Other financing activities was $3.7 million for Q4 2025 at National Health Investors, up from $106000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $7.2 million in Q2 2022 and bottomed at -$11.7 million in Q3 2022.
  • Average Other financing activities over 5 years is -$70266.7, with a median of $175000.0 recorded in 2023.
  • The sharpest move saw Other financing activities crashed 38500.0% in 2021, then soared 1586.27% in 2024.
  • Year by year, Other financing activities stood at -$5.0 million in 2021, then crashed by 76.54% to -$8.9 million in 2022, then surged by 100.58% to $51000.0 in 2023, then skyrocketed by 1586.27% to $860000.0 in 2024, then surged by 333.49% to $3.7 million in 2025.
  • Business Quant data shows Other financing activities for NHI at $3.7 million in Q4 2025, $106000.0 in Q2 2025, and $47000.0 in Q1 2025.